Dérivés du Benzimidazole et de l’Imidazole
Le benzimidazole est un composé constitué d’un noyau benzénique fusionné à un noyau imidazole, une structure à cinq membres contenant deux atomes d’azote. Les dérivés du benzimidazole, comme l’albendazole, sont connus pour leur activité antiparasitaire et antifongique, utilisés dans le traitement des infections parasitaires et de certaines maladies parasitaires chez les animaux et les humains. L’imidazole, quant à lui, est une structure à cinq membres avec deux atomes d’azote, présente dans divers composés biologiquement actifs. Les dérivés de l’imidazole, comme le métronidazole, possèdent des propriétés antimicrobiennes et antiparasitaires. Ces composés sont également utilisés dans l’industrie pharmaceutique pour le traitement des infections bactériennes, des maladies parasitaires et de certaines infections fongiques, ainsi qu’en chimie organique comme catalyseurs.
Chez CymitQuimica, nous proposons des benzimidazoles et des imidazoles de haute pureté pour la recherche en chimie médicinale, pharmacologie et biotechnologie.
10353 produits trouvés pour "Dérivés du Benzimidazole et de l’Imidazole"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5-Hydroxy Omeprazole (~5% Triethylamine as stabilizer)
CAS :<p>Stability Hygroscopic, Temperature Sensitive<br>Applications 5-Hydroxy Omeprazole is the main metabolite of Omeprazole (O635000), which binds covalently to proton pump. It inhibits gastric secretion. Used as an anttiulcerative.<br>References Muller, P., et al.: Arzneimittel-Forsch., 33, 1685 (1983); Wallmark, B., et al.: Biochim. Biophys. Acta., 778, 549 (1984); Morii, M., et al.: J. Biol. chem., 268, 21553 (1993); Ritter, M., et al.: Br. J. Pharmacol., 124, 627 (1998)<br></p>Formule :C17H19N3O4SCouleur et forme :NeatMasse moléculaire :361.42Bis[(1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinyl]-methanone
CAS :Produit contrôlé<p>Applications Bis[(1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinyl]-methanone is a possible impurity of solifenacin (S676700) which is a muscarinic M3 receptor antagoinst. Solifenacin is used in treatment of urinary incontinence.<br>References Ikeda K., et al.: Arch. Pharmacol., 366, 97, (2002); Chapple, C.R., et al.: Br. J. Urol., 93, 303 (2004); Ohtake, A., et al.: Eur. J. Pharmacol., 492, 243 (2004); Brunton, S., et al.: Curr. Med. Res. Opin., 21, 71 (2005); Habb, F., et al.: Eur. Urol. 47, 376 (2005); Payne, C.K., et al.: Drugs, 66, 175 (2006)<br></p>Formule :C31H28N2OCouleur et forme :NeatMasse moléculaire :444.57Lansoprazole Sulfone
CAS :<p>Impurity Lansoprazole USP Related Compound A<br>Applications A metabolite of Lansoprazole, as gastric pump inhibitor. Lansoprazole USP Related Compound A.<br>References De Morais, S., et al.: Mol. Pharmacol., 46, 594 (1994), Spencer, C., et al.: Drugs, 48, 404 (1994), Pearce, R., et al.: J. Pharmacol. Exp. Ther., 277, 805 (1996), Tassaneeyakul, W., et al.: Br. J. Clin. Pharmacol., 49, 139 (2000),<br></p>Formule :C16H14F3N3O3SCouleur et forme :NeatMasse moléculaire :385.365-(3-Bromophenyl)-1-methyl-1H-imidazole
CAS :Degré de pureté :95.0%Masse moléculaire :237.10000610351562(1R,3S,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium Bromide
CAS :Produit contrôlé<p>Impurity Tiotropium bromide EP impurity C<br>Applications (1R,3S,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium Bromide is an impurity in the synthesis of Tiotropium Bromide (T444850), a muscarinic receptor antagonist. Bronchodilator.<br>References Haddad, E.-B., et al.: Mol. Pharmacol., 45, 899 (1994); Donohue, J. F., et al.: Chest, 122, 47 (2002); Profita, M., et al.: Allergy, 60, 1361 (2005); Dusser, D., et al.: Eur. Respir. J., 27, 547 (2006);<br></p>Formule :C19H22NO3S2·BrCouleur et forme :NeatMasse moléculaire :456.42Methyl 2-(1H-imidazol-1-yl)acetate
CAS :Formule :C6H8N2O2Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :140.142(S)-N-Methyl Pregabalin
CAS :Produit contrôlé<p>Stability Hygroscopic<br>Applications The major metabolite of Pregabalin.<br>References Taylor, C.P., at al.: Epilepsy Res., 14, 11 (1993), Field, M.J., et al.: Pain, 80, 391 (1999)<br></p>Formule :C9H19NO2Couleur et forme :NeatMasse moléculaire :173.25Tebuconazole-d9
CAS :Produit contrôlé<p>Applications Isotope labelled Tebuconazole (T013000), which is an ergosterol biosynthesis inhibitor present in most pesticide formulations (1,2). Various uptake is observed in plants (3). Drinking water Contaminant Candidate List 3 - CCL 3 as per United States Environmental Protection Agency (EPA). Environmental contaminants; Food contaminants.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References 1. Grimalt S. et al.: Anal Bioanal Chem. 2015 Apr;407(11):3083-91 2. Gent, D. et al.: Plant Dis. 2003 May:87(5) p591-5973. Wang, C. et al.: Pest. Biochem. Physiol. 2007 Jan:87(1) p1-8<br></p>Formule :C16H13D9ClN3OCouleur et forme :White To Light YellowMasse moléculaire :316.87Oxcarbazepine
CAS :<p>Applications A metabolite of Eslicarbazepine acetate, (BIA 2-093), a novel central nervous system drug. A keto derivative of Carbamazepine. Used as an anticonvulsant. Neuroprotective & Neuroresearch Product.<br>References Dam., M., et al.: Epilepsy Res., 3, 70 (1989); Beydoun, A., et al.: Expert Opin. Pharmacother., 3, 59 (2001);<br></p>Formule :C15H12N2O2Couleur et forme :Light YellowMasse moléculaire :252.275-Bromo-1-(3,4-dimethoxyphenyl)-1H-benzo[d]imidazole
CAS :Degré de pureté :98%Masse moléculaire :333.184997558593753-(1 H -Benzoimidazol-2-yl)-4-chloro-phenylamine
CAS :Degré de pureté :97.0%Couleur et forme :SolidMasse moléculaire :243.69000244140625N-(2-Hydroxyethyl)-5-methyl-1,2,4-oxadiazole-3-carboxamide
CAS :<p>Applications N-(2-Hydroxyethyl)-5-methyl-1,2,4-oxadiazole-3-carboxamide is a photolysis product of Metronidazole (M338880), an antibiotic.<br>References Moore, Douglas E., et al.: Radiation Phy. and Chem., 36(4), 547-50 (1990)<br></p>Formule :C6H9N3O3Couleur et forme :NeatMasse moléculaire :171.154Metronidazole Acetate
CAS :Produit contrôlé<p>Applications Metronidazole Acetate is a protected Metronidazole (M338880). Metronidazole Acetate is an imidazole derivative with anti-trichomonas, antifungal and spermicidal activity.<br>References Kumar, L. et al.: ACS Med. Chem. Lett., 3, 83 (2012); Kumar, L. et al.: Eur. J. Med. Chem., 45, 817 (2010)<br></p>Formule :C8H11N3O4Couleur et forme :NeatMasse moléculaire :213.192-(4-BROMOPHENYL)-2H-INDAZOLE-7-CARBOXAMIDE
CAS :Degré de pureté :95.0%Masse moléculaire :316.157989501953110,11-Dihydro-10-hydroxy Carbamazepine-D4 (Major)
CAS :Produit contrôléFormule :C152H4H10N2O2Couleur et forme :BrownMasse moléculaire :258.312'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-carbaldehyde
CAS :Degré de pureté :98%Masse moléculaire :250.261001586914064-Descarboxamido Rufinamide 4-Methyl Ester
CAS :Produit contrôlé<p>Applications 4-Descarboxamido Rufinamide 4-Methyl Ester is an impurity in the synthesis of Rufinamide (R701550), an antiepileptic triazole derivative which decreases firing by neurons at sodium channels. Anticonvulsant.<br>References Cheung, W.K., et al.: Pharm. Res., 12, 1878 (1995), Cardot, J.-M., et al.: Biopharm. Drug Dispos., 19, 259 (1998), Palhagen, S., et al.: Epilepsy Res., 43, 115 (2001),<br></p>Formule :C11H9F2N3O2Couleur et forme :NeatMasse moléculaire :253.20Glycopyrrolate Bromide-d3 (Mixture of Diastereomers)
CAS :Produit contrôlé<p>Applications Labelled analogue of Glycopyrrolate Bromide, a novel pharmaceutical compound based on PDE IV inhibitors. Glycopyrrolate Bromide is used in the treatment of respiratory complaints.<br>References Gomez, et al.: Br. J. Anaesth., 74, 549 (1995);<br></p>Formule :C19H25D3NO3·BrCouleur et forme :NeatMasse moléculaire :401.356-(1H-imidazol-1-yl)-1,3-benzothiazol-2-amine
CAS :Degré de pureté :95.0%Masse moléculaire :216.25999450683594Iso Letrozole
CAS :<p>Impurity Letrozole EP Impurity A; Letrozole USP Related Compound A<br>Applications Isoletrozole (Letrozole EP Impurity A) is an impurity of Letrozole (L330100). Letrozole impurity A as per USP.<br>References Fleming, F.F., et al.: J. Med. Chem., 53, 7902 (2010),<br></p>Formule :C17H11N5Couleur et forme :NeatMasse moléculaire :285.302,4-Dihydro-4-[4-[4-(4-hydroxyphenyl]-1-piperazinyl]phenyl]-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one
CAS :Produit contrôlé<p>Applications An intermediate in the synthesis of Itraconazole.<br></p>Formule :C22H27N5O2Couleur et forme :NeatMasse moléculaire :393.484-Methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridine 1-oxide
CAS :Degré de pureté :95.0%Masse moléculaire :361.42001342773442-(((6-(Difluoromethoxy)-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,4-dimethoxypyridine 1-oxide
CAS :Degré de pureté :95.00%Masse moléculaire :399.36999511718754-Methoxy-2-nitroaniline(2-Nitro-p-anisidine)
CAS :Produit contrôlé<p>Applications Toxic to some wild and domestic birds and mice. Molluscicidal activity<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References De Abreu, F. et al.; Bioorg. Med. Chem. 9, 659 (2001); Schafer, E.W. et al.; Arch. Environ. Con. Tox. 14, 111 (1985); Schafer, E.W. et al.; Arch. Environ. Con. Tox. 12, 355 (1983)<br></p>Formule :C7H8N2O3Couleur et forme :NeatMasse moléculaire :168.15Rufinamide
CAS :<p>Applications Antiepileptic triazole derivative which decreases firing by neurons at sodium channels. Anticonvulsant. Neuroprotective & Neuroresearch Product.<br>References Cheung, W.K., et al.: Pharm. Res., 12, 1878 (1995), Cardot, J.-M., et al.: Biopharm. Drug Dispos., 19, 259 (1998), Palhagen, S., et al.: Epilepsy Res., 43, 115 (2001),<br></p>Formule :C10H8F2N4OCouleur et forme :White To Off-WhiteMasse moléculaire :238.194-CYCLOPROPYL-1H-IMIDAZOLE
CAS :Formule :C6H8N2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :108.1442-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :343.45001220703125Miconazole Impurity H
CAS :Produit contrôlé<p>Impurity Miconazole EP Impurity H<br>Applications Miconazole Impurity H (Miconazole EP Impurity H), is the impurity of Miconazole (M342500), which is an imidazole antifungal agent, that is applied topically to the skin or to mucus membranes for the treatment of fungal infections.<br>References Godefroi, E.F., et al.: J. Med. Chem., 12, 784 (1969), Brugmans, et al.: Arch. Dermatol., 102, 428 (1970), Heel, R.C., et al.: Drugs, 19, 7 (1980),<br></p>Formule :C18H16Cl2N2OCouleur et forme :NeatMasse moléculaire :347.242,4-Diiodo-1H-imidazole
CAS :Degré de pureté :97.0%Couleur et forme :Solid, Off-white to pale yellow solidMasse moléculaire :319.87200927734375Metronidazole
CAS :<p>Applications Used as an antibacterial in the treatment of rosacea. Antiprotozoal (trichomonas). A potential human carcinogen.<br>References Carballo, M., et al.: J. App. Toxicol., 29, 248 (2009), Leitsch, D., et al.: Mol. Microbiol., 72, 518 (2009), Sanderson, H., et al.: Toxicol. Lett., 187, 84 (2009),<br></p>Formule :C6H9N3O3Couleur et forme :White To Off-WhiteMasse moléculaire :171.151,4-Bis(5-phenyloxazol-2-yl)benzene
CAS :Degré de pureté :95.0%Couleur et forme :Solid, Slightly pale yellow - Pale yellow greenMasse moléculaire :364.40399169921875(2-Oxopyrrolidin-1-yl)acetic Acid
CAS :<p>Impurity Piracetam Impurity D<br>Applications (2-Oxopyrrolidin-1-yl)acetic acid is a reagent in the preparation of pyrazolopyridines as PDE4B inhibitors.<br>References Mitchell, C. J., et al.: Bioorg. Med. Chem. Lett., 20, 5803 (2010);<br></p>Formule :C6H9NO3Couleur et forme :Off-WhiteMasse moléculaire :143.143-Cyclobutyl-1H-indazole
CAS :Degré de pureté :>95%Couleur et forme :Liquid, No data available.Masse moléculaire :172.23100280761721-(3-chloro-2-methylphenyl)-5-phenyl-2,3-dihydro-1H-imidazole-2-thione
CAS :Degré de pureté :98%Masse moléculaire :300.79998779296875para-Clotrimazole Isomer
CAS :Produit contrôlé<p>Impurity Clotrimazole EP Impurity B<br>Applications para-Clotrimazole Isomer (Clotrimazole EP Impurity B) is a positional isomer of the antifungal agent (C587400). It showed agonistic activity on the pregnane X receptor and regulated the levels of apoA1 and HDL-cholesterol in rodents.<br>References Buechel, K.H. et al.: Drugs Made Ger., 15, 79 (1972); Bachmann, K. et al.: Pharmacol. Res., 50, 237 (2004);<br></p>Formule :C22H17ClN2Couleur et forme :NeatMasse moléculaire :344.84Ethyl 5-benzyloxy-1H-indazole-3-carboxylate
CAS :Degré de pureté :95%Masse moléculaire :296.32598876953125Tofenacin Hydrochloride Salt
CAS :Produit contrôlé<p>Applications A metabolite of Orphenadrine (O695300). An antidepressant prodrug. Ondansetron USP Related Compound C.<br>References Watkins, P., et al.: J. Biol. Chem., 261, 6264 (1986), McNeil, C., et al.: Biochem. Pharmacol., 51, 15 (1996), Hiessbock, R., et al.: J. Med. Chem., 42, 1921 (1999),<br></p>Formule :C17H21NO·ClHCouleur et forme :NeatMasse moléculaire :291.82Rivastigmine N-Oxide (Technical Grade)
CAS :Produit contrôlé<p>Applications Rivastigmine N-Oxide is an impurity of Rivastigmine (R541000, Tartrate Salt) which is a brain selective acetylcholinesterase inhibitor.<br>References Rosler, M., et al.: Brit. Med. J., 318, 633 (1999), Enz, A., et al.: Prog. Brain Res., 98, 431 (1993)<br></p>Formule :C14H22N2O3Couleur et forme :Light Yellow LiquidMasse moléculaire :266.34N-[3-(1H-imidazol-1-yl)propyl]-4,5-dimethyl-1,3-benzothiazol-2-amine
CAS :Degré de pureté :95.0%Masse moléculaire :286.3999938964844N-Isopropylnortropine Methobromide (Impurity)
CAS :Produit contrôlé<p>Impurity Ipratropium EP Impurity A<br>Applications N-Isopropylnortropine Methobromide (Ipratropium EP Impurity A) is an impurity of Ipratropium (Bromide Monohydrate: I740500), an Atropine (A794625)-like bronchodilator that acts via an anticholinergic pathway, and is used to treat patients with chronic bronchitis, cardiac obstructive pulmonary disease (COPD) and asthma.<br>References Baigelman, W. & Chodosh, S.: CHEST J., 71, 324 (1977); Groggins, R., et al.: Arch. Dis. Child., 56, 342 (1981); Sichletidis, L., et al.: Int. J. Clin. Prac., 53, 185 (1998)<br></p>Formule :C11H22NO·BrCouleur et forme :White To Off-WhiteMasse moléculaire :264.204-(1h-1,3-Benzodiazol-1-ylmethyl)aniline
CAS :Degré de pureté :95%Masse moléculaire :223.27900695800782-((1,3-DIOXOISOINDOLIN-2-YL)METHYL)OXAZOLE-4-CARBOXYLIC ACID
CAS :Degré de pureté :95.0%Masse moléculaire :272.216003417968751'-Hydroxy Midazolam-β-D-glucuronide-d5
CAS :Produit contrôléFormule :C24H16D5ClFN3O7Couleur et forme :White To Off-WhiteMasse moléculaire :522.92{[4-(1H-benzimidazol-2-yl)cyclohexyl]methyl}amine dihydrochloride
CAS :Degré de pureté :95.0%Masse moléculaire :302.239990234375Omeprazole Sulfone N-Oxide
CAS :<p>Impurity Omeprazole EP Impurity I<br>Applications Omeprazole Sulfone N-Oxide (Omeprazole EP Impurity I) is a metabolite of Omeprazole. Impurity I.<br>References Stevens, C.M., et al.: J. Biol. Chem., 75, 182 (1950), Okamoto, S., et al.: Biochem. Biophys. Res. Commun., 101, 440 (1981)<br></p>Formule :C17H19N3O5SCouleur et forme :NeatMasse moléculaire :377.41Iminostilbene
CAS :Produit contrôlé<p>Impurity Carbamazepine EP Impurity D<br>Applications A metabolite of Carbamazepine (CBZ) (C175840).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lertratanangkoon, K., et al.: Drug Metab. Dispos., 10, 1 (1982), Deleu, D., et al.: Eur. J. Clin. Pharmacol., 57, 243 (2001),<br></p>Formule :C14H11NCouleur et forme :Yellow To Dark OrangeMasse moléculaire :193.24Ternidazole-d6 Hydrochloride (>90%)
CAS :Produit contrôlé<p>Applications Labelled Ternidazole (T116500). An antiparasitic nitroimidazole.<br>References Tramontano, E., et al.: Biochem. Pharmacol., 43, 1371 (1992), Schafer, W., et al.: J. Med. Chem., 36, 726 (1993),<br></p>Formule :C7H6D6ClN3O3Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :227.68Voriconazole-d3
CAS :Produit contrôlé<p>Applications Labelled Vorizonazole (V760000), used as an antifungal (systemic). An Ergosterol Biosynthesis inhibitor.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Sanati, H., et al.: Antimicrob. Ag. Chemother., 41, 2492 (1997),<br></p>Formule :C162H3H11F3N5OCouleur et forme :White To BeigeMasse moléculaire :352.334-Methylpentanal (up to 75% hydrated form)
CAS :Produit contrôlé<p>Applications An intermediate used in the synthesis of Pregabalin (P704800) and related compounds.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Posadas, I., et al.: Br. J. Pharmacol., 142, 331 (2004),<br></p>Formule :C6H12OCouleur et forme :Colourless LiquidMasse moléculaire :100.164-Methyl Mebendazole
CAS :Produit contrôlé<p>Applications Mebendazole (M200500) related compound as anthelmintic agent.<br>References Raeymaekers, A.H.M., et al.: Arzneim.-Forsch., 28, 586 (1978),<br></p>Formule :C17H15N3O3Couleur et forme :NeatMasse moléculaire :309.32Methyl Methanesulfonate
CAS :<p>Applications Methyl Methanesulfonate is used as a reagent in the synthesis of 2-Methyllamotrigine (M315350); an impurity of Lamotrigine (L173250) which is an anticonvulsant that inhibits glutamate release, possible through inhibition of sodium, potassium and calcium currents. Also used in treatment of bipolar depression.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Miller, A.A., et al.: Epilepsia, 27, 483 (1986); Grunze, et al.: Neuropsychobiology, 38, 131 (1998); Calabrese, J.R., et al.: J. Clin. Psychiatry, 60, 79 (1999)<br></p>Formule :C2H6O3SCouleur et forme :Colourless LiquidMasse moléculaire :110.13(R)-Pregabalin
CAS :Produit contrôlé<p>Impurity Pregabalin USP Related Compound A<br>Applications R-Enantiomer of Pregabalin. A GABA analogue used as an anticonvulsant. Anxiolytic analgesic used to treat peripheral neuropathic pain and fibromyalgia (less potent than the S-Enantiomer). Pregabalin USP Related Compound A.<br>References Field, M.J. et al.: Br. J. Pharmacol., 132, 1 (2001); Taylor, C.P., at al.: Epilepsy Res., 14, 11 (1993);<br></p>Formule :C8H17NO2Couleur et forme :WhiteMasse moléculaire :159.23TRAM-34
CAS :Produit contrôlé<p>Applications TRAM-34 blocks intermediate conductance calcium-activated potassium channel IKCa1 with a Kd of 20nM and exhibits exquisite selectivity for the channel. Clotrimazole impurity.<br>References Wulff, H., et al.: J. of Biological Chemistry, 276, 34, 32040 (2001)<br></p>Formule :C22H17ClN2Couleur et forme :NeatMasse moléculaire :344.845-(4-(Benzyloxy)-3-fluorophenyl)oxazole
CAS :Degré de pureté :98%Masse moléculaire :269.27499389648445-(4'-METHYL-1,1'-BIPHEN-2-YL)-1H-TETRAZOLE
CAS :Degré de pureté :95%Masse moléculaire :236.27799987792974,4'-Dicyanobenzophenone
CAS :<p>Applications Letrozole intermediate.<br>References Gomez, R., et al.: J. Mat. Chem., 17, 4274 (2007),<br></p>Formule :C15H8N2OCouleur et forme :Light BrownMasse moléculaire :232.242-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
CAS :Produit contrôlé<p>Applications 2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole is a drug impurity of Lansoprazole, which is a proton pump inhibitor and used to treat stomach and intestinal ulcers.<br>References Figgitt, D., et al.: Drugs, 60, 925 (2000); Katsuki, H., et al.: Eur. J. Clin. Pharmacol., 57, 709 (2001); Barradell, L.B., et al.: Drugs, 44, 225 (1992); Kim, K., et al.: Clin. Pharmacol. Ther., 72, 90 (2002); Niioka, T., et al.: Ther. Drug Monit., 28, 321 (2006)<br></p>Formule :C14H12N4O3SCouleur et forme :NeatMasse moléculaire :316.345-Hydroxy Omeprazole Sodium Salt
CAS :<p>Stability Hygroscopic<br>Applications The main metabolite of Omeprazole.<br>References Renberg, L., et al.: Drug Metab. Dispos., 17, 69 (1989), Calabresi, L., et al.: Pharmacol. Res., 49, 493 (2004), Yin, O., et al.: J. Clin. Pharmacol., 44, 582 (2004),<br></p>Formule :C17H18N3NaO4SCouleur et forme :White To Light YellowMasse moléculaire :383.403-Bromo Zolpidem
Produit contrôléFormule :C19H20BrN3OCouleur et forme :White To Off-WhiteMasse moléculaire :386.294-Nitro-1H-imidazole-1-ethanol
CAS :Produit contrôlé<p>Applications 4-Nitro-1H-imidazole-1-ethanol<br></p>Formule :C5H7N3O3Couleur et forme :WhiteMasse moléculaire :157.13Paclobutrazol
CAS :<p>Applications Paclobutrazol is a triazole fungicide used as an plant growth retardant in inhibiting gibberellin biosynthesis. Paclobutrazol is used in cannabis testing kits as a component of pesticide mixes (P698235).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Hou, X., et al.: Food. Chem., 138, 1198 (2013); Wu, C.W., et al.: Environ. Sci. Technol., 47, 843 (2013);<br></p>Formule :C15H20ClN3OCouleur et forme :WhiteMasse moléculaire :293.79O-Acetyl Scopolamine Hydrobromide
CAS :Produit contrôlé<p>Applications Scopolamine Hydrobromide (S200000) derivative. An acetylcholine antagonist. Used in treatment of motion sickness; antiemetic; antispasmodic; mydriatic; preanesthetic medicant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Brand, J.J., et al.: Lancet, 2, 232 (1970), Bowles, J.B., et al.: Anaesthesia, 34, 476 (1979), Clissold, S.P., et al.: Drugs, 29, 189 (1985), Muhtadi, F.J., et al.: Anal. Profiles Drug Subs., 19, 477 (1990),<br></p>Formule :C19H24BrNO5Couleur et forme :NeatMasse moléculaire :426.32,3-Dichlorobenzoic Acid
CAS :Produit contrôlé<p>Impurity Lamotrigine USP Related Compound B/ Lamotrigine EP Impurity E<br>Applications 2,3-Dichlorobenzoic Acid (Lamotrigine USP Related Compound B) is the key intermediate for antiepileptic drug Lamotrigine (L173250) and other pharmaceuticals for the treatment of central nervous system (CNS) disorders and disease.<br>References Liao Q., et al.: JingXi. Huagong., 36, 18 (2006); Qadeer, G., et al.: J. Brazilian. Chem. Soc., 18, 1176 (2007); Pellon, R.F., et al.: Syn. Commun., 37, 1853 (2007); Wang, J.F., et al.: Thermochimica. Acta., 512, 118 (2011);<br></p>Formule :C7H4Cl2O2Couleur et forme :Off-WhiteMasse moléculaire :191.01Ronidazole
CAS :<p>Applications Antimicrobial.<br>References Yamada, R., et al.: Biosci. Biotechnol. Biochem., 70, 54 (2006), Mohamed, R., et al.: J. Agric. Food Chem., 56, 3500 (2008), Leitsch, D., et al.: Mol. Microbiol., 72, 518 (2009),<br></p>Formule :C6H8N4O4Couleur et forme :Light YellowMasse moléculaire :200.15Isavuconazole-d4
CAS :Produit contrôlé<p>Applications Labelled Isavuconazole (I777832). It is a new triazole currently undergoing phase III clinical trials. This compound has shown in vitro activity against a large number of clinical important yeasts and molds including Aspergillus spp., Fusarium spp., Scedosporium spp., Candida spp., the Zygomycetes and Cryptococcus spp.<br>References Ohwada, J., et al.: Bioorg. Med. Chem. Lett., 13, 191 (2003), Guinea, J., et al.: Antimicrob. Agents Chemother., 52, 1396 (2008)<br></p>Formule :C22H13D4F2N5OSCouleur et forme :White To YellowMasse moléculaire :441.492-(benzylthio)-1H-benzimidazole
CAS :Degré de pureté :95.0%Couleur et forme :Solid, White powderMasse moléculaire :240.320007324218751-[2-(2,4-Dichlorophenyl)-2-[(3,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
CAS :<p>Impurity Miconazole EP Impurity F<br>Applications 1-[2-(2,4-Dichlorophenyl)-2-[(3,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole (Miconazole EP Impurity F) is an impurity of Miconazole (M342505), an antifungal (1,2) agent (topical).<br>References 1. Godefroi, E. et al.: J. Med. Chem. 1969 Sep;12(5):784-91.2. Brugmans, J. et al.: Arch Dermatol. 1970 Oct;102(4):428-32.<br></p>Formule :C18H14Cl4N2OCouleur et forme :NeatMasse moléculaire :416.13Imidacloprid-d4
CAS :Produit contrôlé<p>Applications Imidacloprid-d4 is labelled Imidacloprid (I274990) which is a neonicotinoid, the active ingredient in certain neuro-active insecticides.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Chauzat, M., et al.: Env. Entomol., 38, 514 (2009), Patial, A., et al.: Env. Ecol., 27, 320 (2009), Fernandez-Bayo, J., et al.: J. Agric., Food Chem., 57, 5435 (2009), Tomizawa, M., et al.: J. Med. Chem., 52, 3735 (2009), Chem. and Eng. News 90: 10 (2012)<br></p>Formule :C92H4H6ClN5O2Couleur et forme :WhiteMasse moléculaire :259.69Lansoprazole
CAS :<p>Applications Used as a gastric proton pump inhibitor. An antiulcerative. May limit the severity of tuberculosis (see Chem. and Eng. News. p. 28 July 20 (2018)).<br>References Figgitt, D., et al.: Drugs, 60, 925 (2000), Katsuki, H., et al.: Eur. J. Clin. Pharmacol., 57, 709 (2001), Barradell, L.B., et al.: Drugs, 44, 225 (1992), Kim, K., et al.: Clin. Pharmacol. Ther., 72, 90 (2002), Niioka, T., et al.: Ther. Drug Monit., 28, 321 (2006), Chem. and Eng. News. p. 28 July 20 (2018)<br></p>Formule :C16H14F3N3O2SCouleur et forme :White To Light BeigeMasse moléculaire :369.361'-Hydroxy Triazolam
CAS :Produit contrôlé<p>Applications A metabolite of Triazolam (T767380(M)), which is a sedative; a controlled substance (depressant).<br>References Boxenbaum, H., et al.: J. Pharm. Pharm. Sci., 2, 47 (1999), Perloff, M., et al.: J. Pharmacol. Exp. Ther., 292, 618 (2000), Patki, K., et al.: Drug Metab. Dispos., 31, 938 (2003),<br></p>Formule :C17H12Cl2N4OCouleur et forme :Light GreenMasse moléculaire :359.21Oxazepam-d5
CAS :Produit contrôlé<p>Applications Labelled Oxazepam. Anxiolytic; muscle relaxant (skeletal); anticonvulsant; ligand for the GABAA receptor benzodiazepinemodulatory site.Controlled substance (depressant).<br>References Goldenthal, E.I., et al.: Toxicol. Appl. Pharmacol., 18, 185 (1971), Sisenwine, et al.: Arzneim. Forsch., 22, 682 (1972), Shearer, C.M., et al.: Anal. Profiles Drug Subs., 3, 441 (1974), Greenblatt, D.J., et al.: Clin. Pharmacokinet., 6, 89 (1981),<br></p>Formule :C152H5H6ClN2O2Couleur et forme :Off-WhiteMasse moléculaire :291.743-(1H-Imidazol-4-yl)acrylic acid
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :138.126007080078126-Methyl-2-phenyl-1H-benzo[d]imidazole
CAS :Degré de pureté :95+%Masse moléculaire :208.264007568359386-Hydroxy-2-mercaptobenzimidazole
CAS :Produit contrôléFormule :C7H6N2OSCouleur et forme :NeatMasse moléculaire :166.20(4R,5S)-cis-4,5-Diphenyloxazolidin-2-one
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :239.2740020751953Hydroxy Itraconazole-d8
CAS :Produit contrôlé<p>Applications An isotopically Labelled metabolite of Itraconazole, an orally active antimycotic structurally related to Ketoconazole. It is a COVID19-related research product.<br>References Saag, M., et al.: Antimicrob. Agents Chemother., 32, 1 (1988), Haria, M., et al.: Drugs, 51, 585 (1996), Kousoulos, C., et al.: Anal. Bioanal. Chem., 384,199 (2006),<br></p>Formule :C35D8H30Cl2N8O5Couleur et forme :NeatMasse moléculaire :729.682-Phenyl-1 H -benzoimidazol-4-ylamine
CAS :Couleur et forme :SolidMasse moléculaire :209.25199890136723,3',5,5'-Tetra(1H-imidazol-1-yl)-1,1'-biphenyl
CAS :Degré de pureté :98%Masse moléculaire :418.4639892578125Cyanoacetamide
CAS :<p>Applications Cyanoacetamide has been used in photometric and fluorimetric postcolumn labeling.<br>References Honda S., et. al.: Anal. biochem., 134, 483(1983)<br></p>Formule :C3H4N2OCouleur et forme :NeatMasse moléculaire :84.07672-(4-Morpholinyl)-1H-benzimidazole
CAS :Degré de pureté :95.0%Couleur et forme :Solid, White powderMasse moléculaire :203.24499511718752-(2-Aminoethyl)-1-methyl-1H-imidazole x 2 HCl
CAS :Formule :C6H13Cl2N3Degré de pureté :98.0%Couleur et forme :Liquid, No data available.Masse moléculaire :198.09N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl Lansoprazole
CAS :Produit contrôlé<p>Applications Lansoprazole (L175000) impurity.<br>References Wallmark, B., et al.: J. Gastroenterol., 20, 37 (1985), Barradell, L., et al.: Drugs, 44, 225 (1992), Reddy, K., et al.: Pharmazie, 65, 994 (2006),<br></p>Formule :C25H22F6N4O3SCouleur et forme :Beige To Light BrownMasse moléculaire :572.522-Mercaptobenzimidazole
CAS :Produit contrôlé<p>Impurity Rabeprazole EP Impurity F<br>Applications An antidegradant, protecting rubber from oxidation. An intermediate in the synthesis of Rabeprazole (R070500)<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Beheshti, A., et al.: J. Food Sci., 75, C135 (2010), Rohrig, U., et al.: J. Med. Chem., 53, 1172 (2010),<br></p>Formule :C7H6N2SCouleur et forme :NeatMasse moléculaire :150.205-Benzoyl-1,3-dihydro-2H-benzimidazol-2-one
CAS :Produit contrôlé<p>Applications This compound contains a benzimidazolone moiety which has been seen to inhibit p38 MAP kinase , a crucial protein in the activation of biological factors related to psoriasis, rheumatoid arthritis and other inflammatory diseases.<br>References Hammach, A. et al.: Bioorg. Med. Chem. Lett., 16, 6316 (2006);<br></p>Formule :C14H10N2O2Couleur et forme :NeatMasse moléculaire :238.241’-Hydroxy Midazolam-13C3
CAS :Produit contrôlé<p>Applications A labelled metabolite of Midazolam (M343000).<br>References Dundee, J., et al.: Drugs, 28, 519 (1984), Galetin, A., et al.: Drug Metab. Dispos., 30, 1512 (2002), Uchaipichat, V., et al.: Drug Metab. Dispos., 34, 449 (2006), Lewis, B., et al.: Biochem. Pharmacol., 73, 1463 (2007),<br></p>Formule :C3C15H13ClFN3OCouleur et forme :NeatMasse moléculaire :344.74Triazolam N-Oxide
CAS :Produit contrôlé<p>Applications Triazolam N-Oxide is a derivative of Triazolam (T767380), a sedative.<br>References Lomen, P., et al.: J. Int. Med. Res., 4, 55 (1976); Allens, G.S., et al.: J. Int. Med. Res., 6, 343 (1978); Pakes, G.E., et al.: Drugs, 22, 81 (1981)<br></p>Formule :C17H12Cl2N4OCouleur et forme :NeatMasse moléculaire :359.211-(2-Trifluoromethylphenyl)imidazole
CAS :Formule :C10H7F3N2Degré de pureté :98.0%Couleur et forme :SolidMasse moléculaire :212.175Rufinamide-15N,d2
CAS :Produit contrôlé<p>Applications Labelled Rufinamide (R701552). Antiepileptic triazole derivative which decreases firing by neurons at sodium channels. Anticonvulsant.<br>References Cheung, W.K., et al.: Pharm. Res., 12, 1878 (1995), Cardot, J.-M., et al.: Biopharm. Drug Dispos., 19, 259 (1998), Palhagen, S., et al.: Epilepsy Res., 43, 115 (2001),<br></p>Formule :C10H6D2F2N315NOCouleur et forme :White SolidMasse moléculaire :241.2Lifitegrast
CAS :Produit contrôlé<p>Applications Lifitegrast is used for the treatment of signs and symptons of dry eye diseases. It also Inhibites corneal inflammation that is capable of causing pains, blurred vision and ocular discomfort in sufferer.<br>References Holland, E. J., et al.: Curr. Med. Res. Opin., 32, 1759 (2016); Sun, Y., et al.: J. Ocul. Pharmacol. Ther., 29, 395 (2013);<br></p>Formule :C29H24Cl2N2O7SCouleur et forme :White To Off-WhiteMasse moléculaire :615.4812-Phenylmethanesulfonyl-1h-1,3-benzodiazole
CAS :Degré de pureté :95%Masse moléculaire :272.320007324218754-(4,5-Diphenyl-1H-imidazol-2-yl)benzonitrile
CAS :Degré de pureté :98%Masse moléculaire :321.382995605468753-chloro-4-(1H-indazol-4-yloxy)aniline
CAS :Degré de pureté :95+%Masse moléculaire :259.69000244140625rac 5-Hydroxymethyl Tolterodine-d14
CAS :Produit contrôléFormule :C22H17D14NO2Degré de pureté :90%Couleur et forme :NeatMasse moléculaire :355.57
![Bis[(1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinyl]-methanone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB522610.webp&w=3840&q=75)
![(1R,3S,5S)-3-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-i…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FH941715.webp&w=3840&q=75)
![5-Bromo-1-(3,4-dimethoxyphenyl)-1H-benzo[d]imidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF791539.webp&w=3840&q=75)
![2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-carbaldehyde](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF758868.webp&w=3840&q=75)
![2,4-Dihydro-4-[4-[4-(4-hydroxyphenyl]-1-piperazinyl]phenyl]-2-(1-methylpropyl)-3H-1,2,4-triazol-3-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD449140.webp&w=3840&q=75)
![4-Methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridine 1-oxide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF234476.webp&w=3840&q=75)
![2-(((6-(Difluoromethoxy)-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,4-dimethoxypyridine 1-oxide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF545011.webp&w=3840&q=75)
![2-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF078879.webp&w=3840&q=75)
![N-[3-(1H-imidazol-1-yl)propyl]-4,5-dimethyl-1,3-benzothiazol-2-amine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF495558.webp&w=3840&q=75)
![{[4-(1H-benzimidazol-2-yl)cyclohexyl]methyl}amine dihydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF359612.webp&w=3840&q=75)
![2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM324400.webp&w=3840&q=75)
![1-[2-(2,4-Dichlorophenyl)-2-[(3,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD432038.webp&w=3840&q=75)
![6-Methyl-2-phenyl-1H-benzo[d]imidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF727442.webp&w=3840&q=75)
![N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl Lansoprazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM331010.webp&w=3840&q=75)
